LIVOSTIN

This brand name is authorized in Austria, Finland, Israel, Japan, New Zealand, South Africa.

Active ingredients

The drug LIVOSTIN contains one active pharmaceutical ingredient (API):

1	Levocabastine UNII 124XMA6YEI - LEVOCABASTINE HYDROCHLORIDE
	Levocabastine is a potent, fast-acting and highly selective histamine H1-antagonist with a sustained duration of action.
	Read more about Levocabastine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R01AC02	Levocabastine	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AC Antiallergic agents, excl. corticosteroids
Discover more medicines within R01AC02
S01GX02	Levocabastine	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FI	Lääkealan turvallisuus- ja kehittämiskeskus	077648, 502082
IL	מִשְׂרַד הַבְּרִיאוּת	2813
JP	医薬品医療機器総合機構	1319746Q1029, 1329708Q1038
NZ	Medicines and Medical Devices Safety Authority	6405, 6406
ZA	Health Products Regulatory Authority	X/5.7.1/268